CLEVELAND — Ganeden Biotech is pleased to announce that GanedenBC30 (Bacillus coagulans GBI-30, 6086) is the first probiotic to have a monograph published in the Food Chemical Codex (FCC) from the U.S. Pharmacopeial Convention (“USP”). This means that there are now strain specific standards for testing the identity, concentration and purity of the probiotic, GanedenBC30.
The USP is a scientific nonprofit organization that sets standards for the identity, strength, quality, and purity of ingredients manufactured, distributed and consumed to help safeguard our food supply. Enforced by the United States Food and Drug Administration, these standards are recognized in over 140 countries in order help limit the introduction of potential contaminants at the ingredient level, and serve as a widely acknowledged benchmark in the buying and selling of food ingredients in the global marketplace.
The probiotic monograph is the first of its kind; and due to the unique characteristics of food ingredients made with live organisms and the variances between each probiotic strain, this monograph is specific to the strain Bacillus coagulans GBI-30, 6086 (GanedenBC30).
“The USP is a world renowned, widely respected organization whose commitment to science and the use of quality ingredients is recognized and respected around the world,” said Mike Bush, Ganeden Biotech’s Senior Vice President. “We are honored to receive the first monograph for a probiotic; as it further showcases the strong science supporting GanedenBC30 and illustrates our commitment to the use of only high quality ingredients in the global food and beverage industry”.
The USP standards are housed in the Food Chemical Codex (FCC), a reference guide with the vital measures and analytical methods to validate and determine the quality of food ingredients. The FCC monographs assist manufacturers in ensuring that ingredients are genuine, therefore assuring consumers of a safe food supply chain. This is an asset to consumers and both suppliers and manufacturers in the food industry.
For more information on the U.S. Pharmacopeial Convention (USP) or the Food Chemical Codex (FCC), please visit www.USP.org.
About Ganeden Biotech
Ganeden Biotech is at the forefront of probiotic research and product development with an extensive library of published studies and more than 100 patents for probiotic technologies in the food, beverage, animal health, and personal care ingredients markets. Ganeden is best known for GanedenBC30 (Bacillus coagulans GBI-30, 6086), its patented, FDA GRAS, highly stable probiotic ingredient. Ganeden’s newest ingredient, Bonicel, is the first science-backed, probiotic-derived, personal care ingredient shown to dramatically reduce signs of aging. For more information about Ganeden Biotech and licensing opportunities visit GanedenBiotech.com.
Introducing GanedenBC30® (Bacillus coagulans GBI-30, 6086), Ganeden Biotech’s patented probiotic ingredient that can be found in more than 100 leading food, beverage and companion animal products throughout the world. Unlike most other probiotic strains, GanedenBC30 is a spore- forming organism which makes it highly stable and allows it remain viable through most manufacturing processes, three years of shelf life and the low pH of stomach acid. The efficacy of GanedenBC30 is backed by 17 published studies showing digestive and immune support and GanedenBC30 has an exceptional safety record with FDA GRAS status from the United States FDA. It can be formulated into virtually any product that experiences high or low temperature, pressure or environmental extremes including all hot or refrigerated beverages! For more information, please visit GanedenBiotech.com or GanedenBC30.com.
The U.S. Pharmacopeial Convention (USP)
The U.S. Pharmacopeial Convention (USP) is a global health organization that improves lives through public standards and related programs that help ensure the quality, safety, and benefit of medicines and foods. USP’s standards are used worldwide. For more information about USP, please visit http://www.usp.org.